Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-12-01 Purchase | 2023-12-05 3:50 pm | NKGen Biotech Inc. | NKGN | Graf James A Graf Acquisition Partners IV LLC Interim CFO | 670 | $3.2425 | $2,173 | 2,437,437 (Indirect Direct) | View |
| 2023-11-20 Purchase | 2023-11-22 5:55 pm | NKGen Biotech Inc. | NKGN | Graf James A Graf Acquisition Partners IV LLC Interim CFO | 23 | $2.9259 | $67 | 2,436,767 (Indirect Direct) | View |
| 2021-05-28 Purchase | 2021-06-03 06:03 am | Graf Acquisition Corp. IV | GFOR | Graf James A Chief Executive Officer | 5,000 | $9.9 | $49,500 | 4,237,175 (Direct) | View |
| 2021-05-25 Purchase | 2021-05-27 4:57 pm | Graf Acquisition Corp. IV | GFOR | Graf James A Chief Executive Officer | 500 | $9.9192 | $4,960 | 4,254,300 (Direct) | View |
| 2021-05-21 Purchase | 2021-05-25 7:45 pm | Graf Acquisition Corp. IV | GFOR | Graf James A Chief Executive Officer | 1,300 | $9.9412 | $12,924 | 8,506,300 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-12-20 Other | 2024-12-26 7:20 pm | N/A N/A | NKGen Biotech Inc. | NKGN | Graf Acquisition Partners IV LLC Graf James A 10% Owner | 63,634 | $0 | 3,388,444 (Direct) | View |
| 2024-12-02 Other | 2024-12-23 4:01 pm | N/A N/A | NKGen Biotech Inc. | NKGN | Graf Acquisition Partners IV LLC Graf James A 10% Owner | 290,603 | $0 | 11,790,441 (Direct) | View |
| 2024-12-06 Option Award | 2024-12-10 9:55 pm | N/A 2034-12-06 | NKGen Biotech Inc. | NKGN | Graf James A Chief Financial Officer | 500,000 | $0 | 500,000 (Direct) | View |
Ownership | 2024-06-25 9:49 pm | N/A N/A | Graf Global Corp. | GRAF | Graf Global Sponsor LLC Graf James A Director 10% Owner | 0 | $0 | 5,660,000 (Direct) | View |
| 2023-09-29 Option Award | 2023-10-04 06:10 am | 2023-10-29 2028-09-29 | NKGen Biotech Inc. | NKGN | Graf Acquisition Partners IV LLC Graf James A 10% Owner | 5,244,673 | $1.5 | 14,176,581 (Direct) | View |
| 2023-09-29 Other | 2023-10-04 06:10 am | N/A N/A | NKGen Biotech Inc. | NKGN | Graf Acquisition Partners IV LLC Graf James A 10% Owner | 1,773,631 | $0 | 14,176,581 (Direct) | View |
| 2021-07-14 Other | 2021-07-14 4:54 pm | N/A N/A | Graf Acquisition Corp. IV | GFOR | Graf Acquisition Partners IV LLC Graf James A Chief Executive Officer 10% Owner | 20,000 | $0 | 4,230,375 (Direct) | View |
| 2021-06-02 Other | 2021-06-02 5:13 pm | N/A N/A | Graf Acquisition Corp. IV | GFOR | Graf Acquisition Partners IV LLC Graf James A Chief Executive Officer 10% Owner | 22,125 | $0 | 4,252,500 (Direct) | View |
Ownership | 2021-05-20 6:52 pm | N/A N/A | Graf Acquisition Corp. IV | GFOR | Graf Acquisition Partners IV LLC Graf James A Chief Executive Officer 10% Owner | 0 | $0 | 4,252,500 (Direct) | View |